Vekic Jelena, Topic Aleksandra, Zeljkovic Aleksandra, Jelic-Ivanovic Zorana, Spasojevic-Kalimanovska Vesna
Institute for Medical Biochemistry, Faculty of Pharmacy, Vojvode Stepe 450, P. Box 146, 11000 Belgrade, Serbia.
Clin Biochem. 2007 Mar;40(5-6):310-6. doi: 10.1016/j.clinbiochem.2006.11.013. Epub 2007 Jan 5.
Small, dense LDL particles are associated with an increased risk of coronary heart disease (CHD), and there is growing evidence that small HDL subclasses are less protective than the larger ones. Very limited information is available about the lipoprotein subclasses among populations living in South-East European region, and none for Serbia.
We analyzed the distributions of LDL and HDL subclasses and their relationships with Framingham risk scores (FRS) in 229 Serbian middle-aged asymptomatic individuals. By use of non-denaturing gradient gel electrophoresis, we determined the diameters of LDL and HDL subfractions in a single run.
Comparing to women, men had smaller LDL and HDL particles (P<0.001, and P<0.05, respectively), higher frequency of LDL B phenotype (P<0.005), and significant reduction of HDL2b in favor of HDL2a subclasses (P<0.05). The observed gender-related differences disappeared after the age of 60. We found a significant association of the small LDL particles with high FRS values (P<0.005). A notable incidence of risk lipoprotein phenotypes (LDL B-9.2%; small-sized HDL-9.9%) was found among subjects that were categorized as "low-risk", requiring no further intervention, according to FRS.
Measurement of LDL, and possibly HDL particle size could provide further insight into individual CHD risk, and enable them to benefit from targeted preventive measures.
小而致密的低密度脂蛋白颗粒与冠心病(CHD)风险增加相关,并且越来越多的证据表明,小的高密度脂蛋白亚类的保护作用不如大的亚类。关于东南欧地区人群的脂蛋白亚类的信息非常有限,塞尔维亚则尚无相关信息。
我们分析了229名塞尔维亚中年无症状个体的低密度脂蛋白和高密度脂蛋白亚类分布及其与弗雷明汉风险评分(FRS)的关系。通过使用非变性梯度凝胶电泳,我们在一次实验中测定了低密度脂蛋白和高密度脂蛋白亚组分的直径。
与女性相比,男性的低密度脂蛋白和高密度脂蛋白颗粒更小(分别为P<0.001和P<0.05),低密度脂蛋白B表型的频率更高(P<0.005),并且高密度脂蛋白2b显著减少,有利于高密度脂蛋白2a亚类(P<0.05)。60岁以后,观察到的性别相关差异消失。我们发现小的低密度脂蛋白颗粒与高FRS值之间存在显著关联(P<0.005)。在根据FRS被归类为“低风险”、无需进一步干预的受试者中,发现了显著的风险脂蛋白表型发生率(低密度脂蛋白B为9.2%;小尺寸高密度脂蛋白为9.9%)。
测量低密度脂蛋白以及可能的高密度脂蛋白颗粒大小可以进一步深入了解个体患冠心病的风险,并使他们能够从有针对性的预防措施中受益。